The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Binge Eating Disorder Drug Market Research Report 2024

Global Binge Eating Disorder Drug Market Research Report 2024

Publishing Date : Jul, 2022

License Type :
 

Report Code : 1426930

No of Pages : 87

Ask Your Query

Synopsis
Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychOthersapy, medications and behavioral weight-loss programs.

Due to the COVID-19 pandemic, the global Binge Eating Disorder Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Binge Eating Disorder Drug market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Binge Eating Disorder Drug landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Antidepressants accounting for % of the Binge Eating Disorder Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Retail Pharmacies segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Binge Eating Disorder Drug include Roche, Chronos Therapeutics, Heptares, Novo Nordisk, Omeros Corp, Sunovion Pharmaceuticals and Opiant Pharmaceuticals, etc. In terms of revenue, the global 3 largest players have a % market share of Binge Eating Disorder Drug in 2021.

This report focuses on Binge Eating Disorder Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Binge Eating Disorder Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Binge Eating Disorder Drug Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Antidepressants
  • Anticonvulsants
  • Anti-obesity Medications

Segment by Application

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Roche
  • Chronos Therapeutics
  • Heptares
  • Novo Nordisk
  • Omeros Corp
  • Sunovion Pharmaceuticals
  • Opiant Pharmaceuticals
Index

1 Binge Eating Disorder Drug Market Overview
1.1 Product Overview and Scope of Binge Eating Disorder Drug
1.2 Binge Eating Disorder Drug Segment by Type
1.2.1 Global Binge Eating Disorder Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Antidepressants
1.2.3 Anticonvulsants
1.2.4 Anti-obesity Medications
1.3 Binge Eating Disorder Drug Segment by Application
1.3.1 Global Binge Eating Disorder Drug Sales Comparison by Application: (2022-2028)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Binge Eating Disorder Drug Market Size Estimates and Forecasts
1.4.1 Global Binge Eating Disorder Drug Revenue 2017-2028
1.4.2 Global Binge Eating Disorder Drug Sales 2017-2028
1.4.3 Binge Eating Disorder Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Binge Eating Disorder Drug Market Competition by Manufacturers
2.1 Global Binge Eating Disorder Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Binge Eating Disorder Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Binge Eating Disorder Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Binge Eating Disorder Drug Manufacturing Sites, Area Served, Product Type
2.5 Binge Eating Disorder Drug Market Competitive Situation and Trends
2.5.1 Binge Eating Disorder Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Binge Eating Disorder Drug Players Market Share by Revenue
2.5.3 Global Binge Eating Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Binge Eating Disorder Drug Retrospective Market Scenario by Region
3.1 Global Binge Eating Disorder Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Binge Eating Disorder Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Binge Eating Disorder Drug Market Facts & Figures by Country
3.3.1 North America Binge Eating Disorder Drug Sales by Country
3.3.2 North America Binge Eating Disorder Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Binge Eating Disorder Drug Market Facts & Figures by Country
3.4.1 Europe Binge Eating Disorder Drug Sales by Country
3.4.2 Europe Binge Eating Disorder Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Binge Eating Disorder Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Binge Eating Disorder Drug Sales by Region
3.5.2 Asia Pacific Binge Eating Disorder Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Binge Eating Disorder Drug Market Facts & Figures by Country
3.6.1 Latin America Binge Eating Disorder Drug Sales by Country
3.6.2 Latin America Binge Eating Disorder Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Binge Eating Disorder Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Binge Eating Disorder Drug Sales by Country
3.7.2 Middle East and Africa Binge Eating Disorder Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Binge Eating Disorder Drug Historic Market Analysis by Type
4.1 Global Binge Eating Disorder Drug Sales Market Share by Type (2017-2022)
4.2 Global Binge Eating Disorder Drug Revenue Market Share by Type (2017-2022)
4.3 Global Binge Eating Disorder Drug Price by Type (2017-2022)
5 Global Binge Eating Disorder Drug Historic Market Analysis by Application
5.1 Global Binge Eating Disorder Drug Sales Market Share by Application (2017-2022)
5.2 Global Binge Eating Disorder Drug Revenue Market Share by Application (2017-2022)
5.3 Global Binge Eating Disorder Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Roche Binge Eating Disorder Drug Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Chronos Therapeutics
6.2.1 Chronos Therapeutics Corporation Information
6.2.2 Chronos Therapeutics Description and Business Overview
6.2.3 Chronos Therapeutics Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Chronos Therapeutics Binge Eating Disorder Drug Product Portfolio
6.2.5 Chronos Therapeutics Recent Developments/Updates
6.3 Heptares
6.3.1 Heptares Corporation Information
6.3.2 Heptares Description and Business Overview
6.3.3 Heptares Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Heptares Binge Eating Disorder Drug Product Portfolio
6.3.5 Heptares Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Corporation Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novo Nordisk Binge Eating Disorder Drug Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 Omeros Corp
6.5.1 Omeros Corp Corporation Information
6.5.2 Omeros Corp Description and Business Overview
6.5.3 Omeros Corp Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Omeros Corp Binge Eating Disorder Drug Product Portfolio
6.5.5 Omeros Corp Recent Developments/Updates
6.6 Sunovion Pharmaceuticals
6.6.1 Sunovion Pharmaceuticals Corporation Information
6.6.2 Sunovion Pharmaceuticals Description and Business Overview
6.6.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Sunovion Pharmaceuticals Binge Eating Disorder Drug Product Portfolio
6.6.5 Sunovion Pharmaceuticals Recent Developments/Updates
6.7 Opiant Pharmaceuticals
6.6.1 Opiant Pharmaceuticals Corporation Information
6.6.2 Opiant Pharmaceuticals Description and Business Overview
6.6.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Opiant Pharmaceuticals Binge Eating Disorder Drug Product Portfolio
6.7.5 Opiant Pharmaceuticals Recent Developments/Updates
7 Binge Eating Disorder Drug Manufacturing Cost Analysis
7.1 Binge Eating Disorder Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Binge Eating Disorder Drug
7.4 Binge Eating Disorder Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Binge Eating Disorder Drug Distributors List
8.3 Binge Eating Disorder Drug Customers
9 Binge Eating Disorder Drug Market Dynamics
9.1 Binge Eating Disorder Drug Industry Trends
9.2 Binge Eating Disorder Drug Market Drivers
9.3 Binge Eating Disorder Drug Market Challenges
9.4 Binge Eating Disorder Drug Market Restraints
10 Global Market Forecast
10.1 Binge Eating Disorder Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Binge Eating Disorder Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Binge Eating Disorder Drug by Type (2023-2028)
10.2 Binge Eating Disorder Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Binge Eating Disorder Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Binge Eating Disorder Drug by Application (2023-2028)
10.3 Binge Eating Disorder Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Binge Eating Disorder Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Binge Eating Disorder Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Binge Eating Disorder Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Binge Eating Disorder Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Binge Eating Disorder Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Binge Eating Disorder Drug Market Competitive Situation by Manufacturers in 2021
Table 5. Global Binge Eating Disorder Drug Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Binge Eating Disorder Drug Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Binge Eating Disorder Drug Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Binge Eating Disorder Drug Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Binge Eating Disorder Drug Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Binge Eating Disorder Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Binge Eating Disorder Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Binge Eating Disorder Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Binge Eating Disorder Drug as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Binge Eating Disorder Drug Sales by Region (2017-2022) & (K Units)
Table 16. Global Binge Eating Disorder Drug Sales Market Share by Region (2017-2022)
Table 17. Global Binge Eating Disorder Drug Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Binge Eating Disorder Drug Revenue Market Share by Region (2017-2022)
Table 19. North America Binge Eating Disorder Drug Sales by Country (2017-2022) & (K Units)
Table 20. North America Binge Eating Disorder Drug Sales Market Share by Country (2017-2022)
Table 21. North America Binge Eating Disorder Drug Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Binge Eating Disorder Drug Revenue Market Share by Country (2017-2022)
Table 23. Europe Binge Eating Disorder Drug Sales by Country (2017-2022) & (K Units)
Table 24. Europe Binge Eating Disorder Drug Sales Market Share by Country (2017-2022)
Table 25. Europe Binge Eating Disorder Drug Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Binge Eating Disorder Drug Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Binge Eating Disorder Drug Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Binge Eating Disorder Drug Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Binge Eating Disorder Drug Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Binge Eating Disorder Drug Revenue Market Share by Region (2017-2022)
Table 31. Latin America Binge Eating Disorder Drug Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Binge Eating Disorder Drug Sales Market Share by Country (2017-2022)
Table 33. Latin America Binge Eating Disorder Drug Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Binge Eating Disorder Drug Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Binge Eating Disorder Drug Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Binge Eating Disorder Drug Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Binge Eating Disorder Drug Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Binge Eating Disorder Drug Revenue Market Share by Country (2017-2022)
Table 39. Global Binge Eating Disorder Drug Sales by Type (2017-2022) & (K Units)
Table 40. Global Binge Eating Disorder Drug Sales Market Share by Type (2017-2022)
Table 41. Global Binge Eating Disorder Drug Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Binge Eating Disorder Drug Revenue Share by Type (2017-2022)
Table 43. Global Binge Eating Disorder Drug Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Binge Eating Disorder Drug Sales (K Units) by Application (2017-2022)
Table 45. Global Binge Eating Disorder Drug Sales Market Share by Application (2017-2022)
Table 46. Global Binge Eating Disorder Drug Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Binge Eating Disorder Drug Revenue Share by Application (2017-2022)
Table 48. Global Binge Eating Disorder Drug Price by Application (2017-2022) & (USD/Unit)
Table 49. Roche Corporation Information
Table 50. Roche Description and Business Overview
Table 51. Roche Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Roche Binge Eating Disorder Drug Product
Table 53. Roche Recent Developments/Updates
Table 54. Chronos Therapeutics Corporation Information
Table 55. Chronos Therapeutics Description and Business Overview
Table 56. Chronos Therapeutics Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Chronos Therapeutics Binge Eating Disorder Drug Product
Table 58. Chronos Therapeutics Recent Developments/Updates
Table 59. Heptares Corporation Information
Table 60. Heptares Description and Business Overview
Table 61. Heptares Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Heptares Binge Eating Disorder Drug Product
Table 63. Heptares Recent Developments/Updates
Table 64. Novo Nordisk Corporation Information
Table 65. Novo Nordisk Description and Business Overview
Table 66. Novo Nordisk Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Novo Nordisk Binge Eating Disorder Drug Product
Table 68. Novo Nordisk Recent Developments/Updates
Table 69. Omeros Corp Corporation Information
Table 70. Omeros Corp Description and Business Overview
Table 71. Omeros Corp Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Omeros Corp Binge Eating Disorder Drug Product
Table 73. Omeros Corp Recent Developments/Updates
Table 74. Sunovion Pharmaceuticals Corporation Information
Table 75. Sunovion Pharmaceuticals Description and Business Overview
Table 76. Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Sunovion Pharmaceuticals Binge Eating Disorder Drug Product
Table 78. Sunovion Pharmaceuticals Recent Developments/Updates
Table 79. Opiant Pharmaceuticals Corporation Information
Table 80. Opiant Pharmaceuticals Description and Business Overview
Table 81. Opiant Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Opiant Pharmaceuticals Binge Eating Disorder Drug Product
Table 83. Opiant Pharmaceuticals Recent Developments/Updates
Table 84. Production Base and Market Concentration Rate of Raw Material
Table 85. Key Suppliers of Raw Materials
Table 86. Binge Eating Disorder Drug Distributors List
Table 87. Binge Eating Disorder Drug Customers List
Table 88. Binge Eating Disorder Drug Market Trends
Table 89. Binge Eating Disorder Drug Market Drivers
Table 90. Binge Eating Disorder Drug Market Challenges
Table 91. Binge Eating Disorder Drug Market Restraints
Table 92. Global Binge Eating Disorder Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 93. Global Binge Eating Disorder Drug Sales Market Share Forecast by Type (2023-2028)
Table 94. Global Binge Eating Disorder Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 95. Global Binge Eating Disorder Drug Revenue Market Share Forecast by Type (2023-2028)
Table 96. Global Binge Eating Disorder Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 97. Global Binge Eating Disorder Drug Sales Market Share Forecast by Application (2023-2028)
Table 98. Global Binge Eating Disorder Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 99. Global Binge Eating Disorder Drug Revenue Market Share Forecast by Application (2023-2028)
Table 100. Global Binge Eating Disorder Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 101. Global Binge Eating Disorder Drug Sales Market Share Forecast by Region (2023-2028)
Table 102. Global Binge Eating Disorder Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 103. Global Binge Eating Disorder Drug Revenue Market Share Forecast by Region (2023-2028)
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Binge Eating Disorder Drug
Figure 2. Global Binge Eating Disorder Drug Market Share by Type in 2021 & 2028
Figure 3. Antidepressants Product Picture
Figure 4. Anticonvulsants Product Picture
Figure 5. Anti-obesity Medications Product Picture
Figure 6. Global Binge Eating Disorder Drug Market Share by Application in 2021 & 2028
Figure 7. Retail Pharmacies
Figure 8. Hospital Pharmacies
Figure 9. Online Pharmacies
Figure 10. Global Binge Eating Disorder Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Binge Eating Disorder Drug Market Size (2017-2028) & (US$ Million)
Figure 12. Global Binge Eating Disorder Drug Sales (2017-2028) & (K Units)
Figure 13. Binge Eating Disorder Drug Sales Share by Manufacturers in 2021
Figure 14. Global Binge Eating Disorder Drug Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Binge Eating Disorder Drug Players: Market Share by Revenue in 2021
Figure 16. Binge Eating Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Binge Eating Disorder Drug Sales Market Share by Region (2017-2022)
Figure 18. Global Binge Eating Disorder Drug Sales Market Share by Region in 2021
Figure 19. Global Binge Eating Disorder Drug Revenue Market Share by Region (2017-2022)
Figure 20. Global Binge Eating Disorder Drug Revenue Market Share by Region in 2021
Figure 21. U.S. Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. U.A.E Binge Eating Disorder Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Binge Eating Disorder Drug by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Binge Eating Disorder Drug
Figure 47. Manufacturing Process Analysis of Binge Eating Disorder Drug
Figure 48. Binge Eating Disorder Drug Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock